Genomics for risk-based cancer screening to improve health outcomes

The Australian Cancer Risk Study is a collaborative research program on genomic risk prediction and risk-based screening and early detection for the four most common cancers in Australia – breast, prostate, melanoma and colorectal cancers.

Cancer remains one of Australia’s most significant health challenges. Over 82,000 Australians are diagnosed with the four most common cancers (prostate, breast, melanoma and colorectal cancers) every year, accounting for almost half of all new cancer diagnoses.

Early detection of cancers is vital to improve survival, reduce cancer burden, and help Australians live longer, healthier lives. The Australian Cancer Risk Study aims to identify whether and how genomics could be used to effectively improve early detection by tailoring screening recommendations to people’s risk of cancer.

The Australian Cancer Risk Study is co-lead by Prof. Anne Cust and A/Prof. Julia Steinberg.

Our Key Goals

Generate a new lasting resource of Australian genomic data

Generate a new
lasting resource of
Australian genomic data

Learn More

Evaluate genomic cancer
risk predictions

Learn More

Establish community preferences for genomic risk assessment and risk-based screening

Learn More

Evaluate benefits, harms and costs of potential risk-based screening and early detection strategies

Learn More

Genomics for risk-based cancer screening to improve health outcomes

The Australian Cancer Risk Study is a collaborative research program on genomic risk prediction and risk-based screening and early detection for the four most common cancers in Australia – breast, prostate, melanoma and colorectal cancers.

Our Key Goals

Generate a new lasting resource of Australian genomic data

Generate a new
lasting resource of
Australian genomic data

Evaluate genomic cancer
risk predictions

Establish community preferences for genomic risk assessment and risk-based screening

Evaluate benefits, harms and costs of potential risk-based screening and early detection strategies

Interested in staying up to date?

Subscribe to the Australian Cancer Risk Study online newsletter to receive key updates and highlights delivered to your inbox 2-4 times a year.

Genomics for risk-based cancer screening to improve health outcomes

The Australian Cancer Risk Study is a collaborative research program on genomic risk prediction and risk-based screening and early detection for the four most common cancers in Australia – breast, prostate, melanoma and colorectal cancers.

Our Key Goals

Generate a new lasting resource of Australian genomic data

Generate a new lasting resource of Australian genomic data

Evaluate genomic cancer risk predictions

Establish community preferences for genomic risk assessment and risk-based screening

Evaluate benefits, harms and costs of potential risk-based screening and early detection strategies

Interested in staying up to date?

Subscribe to the Australian Cancer Risk Study online newsletter to receive key updates and highlights delivered to your inbox 2-4 times a year.

Generate a new
lasting resource of
Australian genomic data

Evaluate genomic cancer
risk predictions